Physician profile
Henry Mentz
NPI 1821163429
$27,284.25
in general payments reported to CMS, 2019-2025
19 companies · $4,661 in 2025
The $4,661 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,615 · 2020: $1,719 · 2021: $3,921 · 2022: $1,160 · 2023: $4,434 · 2024: $7,775 · 2025: $4,661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,840 · Food and Beverage: $8,005 · Education: $25.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,840.00 |
| Food and Beverage | $8,004.98 |
| Education | $25.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $10,514.00 | 2023-2025 | Surgimend, Codman Certas, Integra |
| Merz North America, INC. | $4,006.58 | 2019-2022 | |
| Sientra, INC. | $2,979.63 | 2019-2022 | |
| Revance Therapeutics, INC. | $2,759.36 | 2024-2025 | Daxxify |
| Motiva USA, LLC | $1,766.08 | 2024-2025 | |
| Allergan, INC. | $1,343.01 | 2019-2022 | |
| Mentor Worldwide LLC | $1,115.95 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander |
| Abbvie INC. | $890.41 | 2023-2025 | |
| Davol INC. | $593.39 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $466.59 | 2021 | |
| Tepha INC | $208.36 | 2019 | |
| Galderma Laboratories, L.P. | $193.61 | 2019-2021 | |
| Musculoskeletal Transplant Foundation INC. | $121.07 | 2024 | |
| Acelrx Pharmaceuticals, INC. | $120.09 | 2020 | |
| Ethicon US, LLC | $116.32 | 2021-2025 | Megadyne, Dermabond Prineo, Ethicon |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $37.34 | 2024 | Ovitex 2s |
| Kci USA, INC. | $23.05 | 2021 | |
| Biotissue Holdings INC. | $15.26 | 2023 | |
| Medline Industries Lp | $14.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Mentz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.